{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:43Z","timestamp":1791357283328,"version":"4.3.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Neuropsychopharm."],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1017\/s1461145704004134","type":"journal-article","created":{"date-parts":[[2004,2,19]],"date-time":"2004-02-19T11:27:03Z","timestamp":1077190023000},"page":"S21-S25","source":"Crossref","is-referenced-by-count":23,"title":["How do we choose between atypical antipsychotics? The advantages of amisulpride"],"prefix":"10.1093","volume":"7","author":[{"given":"Ann M.","family":"Mortimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["The International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/7\/Supplement_1\/S21\/3021897\/7-Supplement_1-S21.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T13:52:56Z","timestamp":1503496376000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article-lookup\/doi\/10.1017\/S1461145704004134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999]]}},"alternative-id":["S1461145704004134"],"URL":"https:\/\/doi.org\/10.1017\/s1461145704004134","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}